RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보 SCOPUS SCIE

      Effect of Casein Hydrolysate, Prepared with Protease Derived from Aspergillus oryzae, on Subjects with High-Normal Blood Pressure or Mild Hypertension

      한글로보기

      https://www.riss.kr/link?id=A104510403

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Casein hydrolysate, prepared with Aspergillus oryzaeprotease, contains angiotensin I-converting enzyme in-hibitory peptides, such as Val-Pro-Pro and Ile-Pro-Pro. We conducted a randomized, double-blind, placebo-controlled studyto evaluate the effect o...

      Casein hydrolysate, prepared with Aspergillus oryzaeprotease, contains angiotensin I-converting enzyme in-hibitory peptides, such as Val-Pro-Pro and Ile-Pro-Pro. We conducted a randomized, double-blind, placebo-controlled studyto evaluate the effect of casein hydrolysate on the blood pressure of 144 subjects with high-normal blood pressure (n . 104)and mild hypertension (n . 40). Subjects were randomly assigned to two groups for a 12-week intake period. In the test group,both systolic (SBP) and diastolic (DBP) blood pressure decreased significantly compared with the placebo group: SBP/DBPsignificantly decreased from 138.2. 6.5/84.4. 5.3 mm Hg at week 0 to 132.3. 7.3 (P. .001)/81.2. 4.8 mm Hg (P..001) at week 12. In the stratified analysis, the test product showed an antihypertensive effect in both the subject group withhigh-normal blood pressure and that with mild hypertension. No side effect was observed in any subjects in this study. Theseresults demonstrate that the casein hydrolysate, prepared with A. oryzaeprotease, produced a significant reduction in bloodpressure in a population of subjects with high-normal blood pressure or mild hypertension without an adverse event.

      더보기

      참고문헌 (Reference)

      1 "cholesterol and stroke in EasternAsia. Lancet 1998" Blood pressure 1801?1807.

      2 "andcoronary heart disease. Part 1. Prolonged differences in bloodpressure prospective observational studies corrected for the regressiondilution bias. Lancet 1990" Blood pressure

      3 "World Health Organization-InternationalSociety of Hypertension guidelines for the managementof hypertension. J Hypertens 1999" 1999

      4 "Val-Tyr as a natural antihypertensive dipeptide can be absorbedinto the human circulatory blood system." 2002

      5 "Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco- 2 cell monolayers." 2002

      6 "The Joint National Committee on Prevention and Treatment of High Blood Pressure The sixth report ofthe Joint National Committee on Prevention and Treatment of High Blood Pressure" 1997

      7 "Structures and activity of angiotensin-converting enzymeinhibitors in an a-zein hydrolysate. Agric Biol Chem 1991"

      8 "Sodium reductionand weight loss in the treatment of hypertension in order persons.A randomized controlled trial of nonpharmacologic interventionsin the elderly" 1998

      9 "Releaseof short and proline rich antihypertensive peptides from caseinhydrolyzate with an Aspergillus oryzae protease. J Dairy Sci2004" 2004

      10 "Quantitative analysis of antihypertensive peptides in casein hydrolyzate with Aspergillus oryzaeprotease by a LC-MS method. Milchwissenschaft 2005" 2005

      1 "cholesterol and stroke in EasternAsia. Lancet 1998" Blood pressure 1801?1807.

      2 "andcoronary heart disease. Part 1. Prolonged differences in bloodpressure prospective observational studies corrected for the regressiondilution bias. Lancet 1990" Blood pressure

      3 "World Health Organization-InternationalSociety of Hypertension guidelines for the managementof hypertension. J Hypertens 1999" 1999

      4 "Val-Tyr as a natural antihypertensive dipeptide can be absorbedinto the human circulatory blood system." 2002

      5 "Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco- 2 cell monolayers." 2002

      6 "The Joint National Committee on Prevention and Treatment of High Blood Pressure The sixth report ofthe Joint National Committee on Prevention and Treatment of High Blood Pressure" 1997

      7 "Structures and activity of angiotensin-converting enzymeinhibitors in an a-zein hydrolysate. Agric Biol Chem 1991"

      8 "Sodium reductionand weight loss in the treatment of hypertension in order persons.A randomized controlled trial of nonpharmacologic interventionsin the elderly" 1998

      9 "Releaseof short and proline rich antihypertensive peptides from caseinhydrolyzate with an Aspergillus oryzae protease. J Dairy Sci2004" 2004

      10 "Quantitative analysis of antihypertensive peptides in casein hydrolyzate with Aspergillus oryzaeprotease by a LC-MS method. Milchwissenschaft 2005" 2005

      11 "Purification and characterization of angiotensin I-convertingenzyme inhibitors from sour milk." taka (taka): 1995

      12 "Prolonged normotentionfollowing cessation of therapy in uncomplicated essential hypertension.Clin Invest Med 1982"

      13 "Peptides inhibitors for angiotensinI-converting enzyme from thermolysin digest of driedbonito. Biosci Biotechnol Biochem 1992"

      14 "Peptide hydrolyses in thebrush border and soluble fractions of small intestinal mucosa ofrat and man. J Clin Invest 1972"

      15 "Observational studies of salt and blood pressure. Hypertension1991" 1-,

      16 "Long-term intake of milk peptides attenuates developmentof hypertension in spontaneously hypertensive rats" Finckenberg P .2001

      17 "Joint National Committee on Prevention and Treatment of High Blood Pressure The seventh report of theJoint National Committee on Prevention and Treatment of High Blood Pressure" .2003

      18 "Hypotensive effect of sour milk drink on mild and moderatehypertensive subjects" 2001

      19 "Estimationof 24-hour urinary sodium and potassium excretion from predictedvalue of 24-hour urinary creatinine excretion and fractional urinesodium/creatinine and potassium/creatinine ratio. In SeventhSymposium on Salt" uezo 2 (uezo 2): 257262-, 1993

      20 "Effects of withdrawing diuretictherapy on blood pressure in mild hypertension. Hypertension1983"

      21 "Effects of the liquidyogurts containing ?lactotripeptide ? on high-normalblood pressure" j2004

      22 "Effect of long-term intake of milk products on blood pressure inhypertensive rats." Finckenberg P 2002

      23 "Effect of an ace-inhibitoryagent in the spontaneously hypertensiverat and in borderline and mildly hypertensive subjects." 2001

      24 "Does potassium supplementationlower blood pressure? A meta-analysis of published trials. J Hypertens1991"

      25 "Decrease of tissue angiotensinI-converting enzyme activity upon feeding sour milk in spontaneouslyhypertensive rats. Biosci Biotechnol Biochem 1996" taka (taka): 1996

      26 "Clinical trial of the effectsof dietary patterns on blood pressure." 1997

      27 "Blood pressure reduction and vasodialatory effects invivo of peptides originating from sardine muscle. Clin Rep1991"

      28 "Antihypertensiveeffect of sour milk and peptides isolated from it that are inhibitorsto angiotensin I-converting enzyme. J Dairy Sci 1995" taka (taka): 1995

      29 "Antihypertensive peptidesare present in aorta after oral administration of sour milk containingthese peptides to spontaneously hypertensive rats. J Nutr1996" taka (taka): 1996

      30 "Antihypertensive effectof casein hydrolyzate with Aspergillus oryzae protease by aplacebo-controlled clinical study for subjects with high-normalblood pressure and mild hypertension. Br J Nutr 2005"

      31 "Antihypertensive effect of valyl-tyrosine, a short chain peptide derived from sardine musclehydrolyzate" 2000

      32 "Angiotensinconvertingenzyme inhibitor derived from an enzymatic hydrolysateof casein. II. Isolation and bradykinin-potentiating activityon the uterus and the ileum of rats. Agric Biol Chem1985"

      33 "Age-specificrelevance of usual blood pressure to vascular mortality." 2002

      34 "A saturable tissue angiotensin Iconverting enzyme binding model for the pharmacokinetic analysisof Imidapril and its active metabolite in human." 1995

      35 "A placebo-controlled study of sour milk on blood pressurein hypertensive subjects." taka (taka): 1996

      36 "A long-term follow-up ofpatients with essential hypertension treated with captopril. ActaMed Scand 1984"

      37 "A fermented milkhigh in bioactive peptides has a blood pressure-lowering effect inhypertensive subjects. Am J Clin Nutr 2003" 2003

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2014-06-24 학회명변경 한글명 : 한국식품영양과학회지 -> 한국식품영양과학회
      영문명 : Journal of the Korean Society of Food Science and Nutrition -> The Korean Society of Food Science and Nutrition
      KCI등재
      2014-04-02 학회명변경 한글명 : 한국식품영양과학회 -> 한국식품영양과학회지
      영문명 : 미등록 -> Journal of the Korean Society of Food Science and Nutrition
      KCI등재
      2013-10-01 평가 SCOPUS 등재 (등재유지) KCI등재
      2010-01-01 평가 SCI 등재 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-01-20 학술지등록 한글명 : Journal of Medicinal Food
      외국어명 : Journal of Medicinal Food
      KCI등재후보
      2005-01-20 학술지등록 한글명 : Journal of Medicinal Food
      외국어명 : Journal of Medicinal Food
      KCI등재후보
      2004-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.88 0.33 1.35
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.09 0.84 0.536 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼